Cargando…

Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation

Early and strong interferon type I (IFN-I) responses are usually associated with mild COVID-19 disease, whereas persistent or unregulated proinflammatory cytokine responses are associated with severe disease outcomes. Previous work suggested that monocyte-derived macrophages (MDMs) are resistant and...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Nicolás, O., Godel, A., Zimmer, G., Summerfield, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227409/
https://www.ncbi.nlm.nih.gov/pubmed/37253946
http://dx.doi.org/10.1038/s41423-023-01039-4
_version_ 1785050765299023872
author García-Nicolás, O.
Godel, A.
Zimmer, G.
Summerfield, A.
author_facet García-Nicolás, O.
Godel, A.
Zimmer, G.
Summerfield, A.
author_sort García-Nicolás, O.
collection PubMed
description Early and strong interferon type I (IFN-I) responses are usually associated with mild COVID-19 disease, whereas persistent or unregulated proinflammatory cytokine responses are associated with severe disease outcomes. Previous work suggested that monocyte-derived macrophages (MDMs) are resistant and unresponsive to SARS-CoV-2 infection. Here, we demonstrate that upon phagocytosis of SARS-CoV-2-infected cells, MDMs are activated and secrete IL-6 and TNF. Importantly, activated MDMs in turn mediate strong activation of plasmacytoid dendritic cells (pDCs), leading to the secretion of high levels of IFN-α and TNF. Furthermore, pDC activation promoted IL-6 production by MDMs. This kind of pDC activation was dependent on direct integrin-mediated cell‒cell contacts and involved stimulation of the TLR7 and STING signaling pathways. Overall, the present study describes a novel and potent pathway of pDC activation that is linked to the macrophage-mediated clearance of infected cells. These findings suggest that a high infection rate by SARS-CoV-2 may lead to exaggerated cytokine responses, which may contribute to tissue damage and severe disease. [Image: see text]
format Online
Article
Text
id pubmed-10227409
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102274092023-06-01 Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation García-Nicolás, O. Godel, A. Zimmer, G. Summerfield, A. Cell Mol Immunol Article Early and strong interferon type I (IFN-I) responses are usually associated with mild COVID-19 disease, whereas persistent or unregulated proinflammatory cytokine responses are associated with severe disease outcomes. Previous work suggested that monocyte-derived macrophages (MDMs) are resistant and unresponsive to SARS-CoV-2 infection. Here, we demonstrate that upon phagocytosis of SARS-CoV-2-infected cells, MDMs are activated and secrete IL-6 and TNF. Importantly, activated MDMs in turn mediate strong activation of plasmacytoid dendritic cells (pDCs), leading to the secretion of high levels of IFN-α and TNF. Furthermore, pDC activation promoted IL-6 production by MDMs. This kind of pDC activation was dependent on direct integrin-mediated cell‒cell contacts and involved stimulation of the TLR7 and STING signaling pathways. Overall, the present study describes a novel and potent pathway of pDC activation that is linked to the macrophage-mediated clearance of infected cells. These findings suggest that a high infection rate by SARS-CoV-2 may lead to exaggerated cytokine responses, which may contribute to tissue damage and severe disease. [Image: see text] Nature Publishing Group UK 2023-05-30 2023-07 /pmc/articles/PMC10227409/ /pubmed/37253946 http://dx.doi.org/10.1038/s41423-023-01039-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
García-Nicolás, O.
Godel, A.
Zimmer, G.
Summerfield, A.
Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
title Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
title_full Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
title_fullStr Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
title_full_unstemmed Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
title_short Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
title_sort macrophage phagocytosis of sars-cov-2-infected cells mediates potent plasmacytoid dendritic cell activation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227409/
https://www.ncbi.nlm.nih.gov/pubmed/37253946
http://dx.doi.org/10.1038/s41423-023-01039-4
work_keys_str_mv AT garcianicolaso macrophagephagocytosisofsarscov2infectedcellsmediatespotentplasmacytoiddendriticcellactivation
AT godela macrophagephagocytosisofsarscov2infectedcellsmediatespotentplasmacytoiddendriticcellactivation
AT zimmerg macrophagephagocytosisofsarscov2infectedcellsmediatespotentplasmacytoiddendriticcellactivation
AT summerfielda macrophagephagocytosisofsarscov2infectedcellsmediatespotentplasmacytoiddendriticcellactivation